Astellas Pharma Europe, Ltd. Deal History & Licensing Activity
Astellas Pharma Europe, Ltd. is a life sciences. Over the past three years, Astellas Pharma Europe, Ltd. has been involved in 1 licensing and acquisition transaction, with a primary focus on ADC (2 deals). The company currently has 3 active clinical trials, primarily in Women's Health.
Deals (12mo)
1
Active Trials
3
Top Modality
ADC
Focus Area
Women's Health
Astellas Pharma Europe, Ltd. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Astellas Pharma Europe, Ltd. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| XNW27011 | Astellas Pharma | ADC | Unknown | license | May 2025 |
Astellas Pharma Europe, Ltd. Pipeline Focus
Therapeutic areas and modalities where Astellas Pharma Europe, Ltd. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Astellas Pharma Europe, Ltd. Clinical Pipeline
Astellas Pharma Europe, Ltd. has 3 active clinical trials across 3 development phases.
1
Unknown
1
Phase 2
1
Phase 3
See How Your Asset Matches Astellas Pharma Europe, Ltd.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Women's Health assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Women's Health Deal Benchmarks
Market sizing, deal terms, and competitive landscape for women's health
ADC Benchmarks
Upfront, milestone, and royalty benchmarks for adc deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Astellas Pharma Europe, Ltd. Licensing & Deal Activity
Astellas Pharma Europe, Ltd. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Astellas Pharma Europe, Ltd. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Astellas Pharma Europe, Ltd. include Women's Health (2 deals and trials), and Solid Tumors (2 deals and trials). In terms of modality, Astellas Pharma Europe, Ltd. has shown particular interest in adc.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Astellas Pharma Europe, Ltd. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Astellas Pharma Europe, Ltd.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.